Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.
- Published In:
- JHEP reports : innovation in hepatology, 7(11), 101483 (2025)
- Authors:
- Browne, Sarah K, Suschak, John J, Tomah, Shaheen, Gutierrez, Julio A, Yang, Jay, Georges, Bertrand, Roberts, M Scot, Harris, M Scott
- Database ID:
- RPEP-10236
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10236APA
Browne, Sarah K; Suschak, John J; Tomah, Shaheen; Gutierrez, Julio A; Yang, Jay; Georges, Bertrand; Roberts, M Scot; Harris, M Scott. (2025). Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.. JHEP reports : innovation in hepatology, 7(11), 101483. https://doi.org/10.1016/j.jhepr.2025.101483
MLA
Browne, Sarah K, et al. "Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.." JHEP reports : innovation in hepatology, 2025. https://doi.org/10.1016/j.jhepr.2025.101483
RethinkPeptides
RethinkPeptides Research Database. "Safety and efficacy of 24 weeks of pemvidutide in metabolic ..." RPEP-10236. Retrieved from https://rethinkpeptides.com/research/browne-2025-safety-and-efficacy-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.